Back

Antiviral Sulfonated Polymersomes Inhibit Corona-, Influenza-, and Alphavirus

McCabe, S.; Zhu, R.; Setia, R. Y.; Brown, J. C.; Pan, Z.; Zhu, X.; Xu, X.; Kaya, B.; Wong, I.; Koropouli, F.; Londono, P. S.; Mok, K. Y.; Kugathasan, R.; Rifaie-Graham, O.; Torraca, V.; Galao, R. P.; Barclay, W. S.; Najer, A.

2026-10-11 bioengineering
10.64898/2026.10.11.758302 bioRxiv
Show abstract

A broad-spectrum antiviral is required to enable rapid intervention against current, newly emerging and mutating viruses. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A virus (IAV), Sindbis virus (SINV) and chikungunya virus (CHIKV) all engage negatively charged moieties on host cells, such as heparan sulfate (HS) and sialic acid, to facilitate attachment for entry and infection. We designed HS-mimetic nanoparticles in the form of polymer vesicles (polymersomes) by blending membrane-forming and sulfonated copolymers. These biocompatible polymersomes successfully inhibited host cell infection of HS-dependent SARS-CoV-2 and HS-independent IAV in vitro with sub-nanomolar potency. Multivalent interaction of several virus ligands with a single polymersome as quantified by fluorescence correlation spectroscopy likely contributes to their potency. The sulfonated polymersomes also functioned in vivo as demonstrated by a reduction in the spread of SINV, an alphavirus model for CHIKV, in zebrafish embryos, which led to a significantly increased survival. Hence, our polymersomes could form the basis for an urgently required multifunctional broad-spectrum antiviral nanomedicine.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.